122 filings
PRE 14A
BVS
Bioventus Inc - Ordinary Shares
10 Apr 24
Preliminary proxy
4:08pm
S-8
BVS
Bioventus Inc - Ordinary Shares
20 Mar 24
Registration of securities for employees
4:08pm
10-K
2023 FY
BVS
Bioventus Inc - Ordinary Shares
Annual report
12 Mar 24
7:51am
8-K
BVS
Bioventus Inc - Ordinary Shares
12 Mar 24
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
7:45am
8-K
BVS
Bioventus Inc - Ordinary Shares
19 Jan 24
Entry into a Material Definitive Agreement
8:27am
8-K
br9hy2
12 Jan 24
Departure of Directors or Certain Officers
5:10pm
S-8
wosglp
9 Jan 24
Registration of securities for employees
8:55am
8-K
7ybdx zyof
21 Dec 23
Bioventus Names Robert Claypoole as President and Chief Executive Officer
8:00am
8-K
u1e3wwq
7 Nov 23
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
7:35am
8-K
rd11 b2dv8
8 Aug 23
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
8:02am
S-8
mnwxl
16 Jun 23
Registration of securities for employees
4:56pm
8-K
ip4ovu6o53u5p469pa
9 Jun 23
Departure of Directors or Certain Officers
5:04pm
8-K
m4q8f6
26 May 23
Bioventus Completes Divestiture of its Wound Business
8:39am
8-K
g4nex
16 May 23
Bioventus Reports First Quarter Financial Results
4:25pm
8-K
r244os
16 May 23
Bioventus Announces Divestiture of its Wound Business
8:15am
NT 10-Q
u8k6xpxo1zoz dswx2wx
11 May 23
Notice of late quarterly filing
4:59pm
8-K
nrc2khduzst
11 May 23
Results of Operations and Financial Condition
8:56am